CHRISTINA RODRIGUEZ: Open Payments
NPI 1487294369 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 15 payments from 10 companies in 2025. Trend: 2023 $855 · 2024 $439 · 2025 $721
Food & beverage: $546Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $202 |
| ABIOMED | 2 | $124 |
| Amarin Pharma, Inc. | 1 | $113 |
| Insulet Corporation | 1 | $90 |
| Novo Nordisk Inc | 3 | $69 |
| Vertex Pharmaceuticals Incorporated | 1 | $35 |
| Alcresta Therapeutics, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $26 |
| Dexcom, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: PROLIA, Vascepa, Omnipod, Wegovy, JOURNAVX, RELIZORB, EVENITY, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
